Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
8,896,104
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
281,569
-
Shares change
-
+11,753
-
Total reported value, excl. options
-
$403,059
-
Value change
-
+$6,035
-
Number of buys
-
4
-
Number of sells
-
-5
-
Price
-
$1.43
Significant Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) as of Q4 2024
17 filings reported holding BRTX - BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value as of Q4 2024.
BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 281,569 shares
of 8,896,104 outstanding shares and own 3.17% of the company stock.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (54,722 shares), StoneX Group Inc. (50,143 shares), Wealth Alliance (40,000 shares), MORGAN STANLEY (27,500 shares), CITADEL ADVISORS LLC (21,481 shares), VANGUARD GROUP INC (20,472 shares), STATE STREET CORP (20,459 shares), US FINANCIAL ADVISORS, LLC (17,142 shares), UBS Group AG (16,297 shares), and Newman Dignan & Sheerar, Inc. (11,522 shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.